These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 12640971)

  • 21. Human pharmacogenomic variation of antihypertensive drugs: from population genetics to personalized medicine.
    Polimanti R; Iorio A; Piacentini S; Manfellotto D; Fuciarelli M
    Pharmacogenomics; 2014 Feb; 15(2):157-67. PubMed ID: 24444406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Individual response to drug therapy: bases and study approaches.
    León-Cachón RB; Ascacio-Martínez JA; Barrera-Saldaña HA
    Rev Invest Clin; 2012; 64(4):364-76. PubMed ID: 23227587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Individualized tailoring of antihypertensive therapy].
    Nakazawa I; Umemura S
    Nihon Rinsho; 2002 Jan; 60(1):137-42. PubMed ID: 11808324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical impact of adducin polymorphism.
    Bianchi G; Manunta P; Glorioso N
    J Hypertens; 2009 Jun; 27(6):1325-7; author reply 1327-9. PubMed ID: 19454906
    [No Abstract]   [Full Text] [Related]  

  • 25. Genetic variability in cytochrome P450 3A5 and in vivo cytochrome P450 3A activity: some answers but still questions.
    Wilkinson GR
    Clin Pharmacol Ther; 2004 Aug; 76(2):99-103. PubMed ID: 15289786
    [No Abstract]   [Full Text] [Related]  

  • 26. ACE2: A novel therapeutic target for cardiovascular diseases.
    Der Sarkissian S; Huentelman MJ; Stewart J; Katovich MJ; Raizada MK
    Prog Biophys Mol Biol; 2006; 91(1-2):163-98. PubMed ID: 16009403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacogenetics in HIV therapy.
    Rodríguez-Nóvoa S; Barreiro P; Jiménez-Nacher I; Rendón A; Soriano V
    AIDS Rev; 2005; 7(2):103-12. PubMed ID: 16092504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cardiovascular pharmacogenomics].
    Ahlehoff O; Hansen PR
    Ugeskr Laeger; 2009 Apr; 171(17):1405-7. PubMed ID: 19413939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acetylator status, drug metabolism and disease.
    Pande JN; Pande A; Singh SP
    Natl Med J India; 2003; 16(1):24-6. PubMed ID: 12715953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytochrome P450 polymorphism--molecular, metabolic, and pharmacogenetic aspects. III. Influence of CYP genetic polymorphism on population differentiation of drug metabolism phenotype.
    Tomaszewski P; Kubiak-Tomaszewska G; Łukaszkiewicz J; Pachecka J
    Acta Pol Pharm; 2008; 65(3):319-29. PubMed ID: 18646551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacogenetics in pain management: the clinical need.
    Webster LR
    Clin Lab Med; 2008 Dec; 28(4):569-79. PubMed ID: 19059063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Genetics and hypertension].
    Ellervik C; Tarnow L; Pedersen EB
    Ugeskr Laeger; 2009 Jun; 171(24):2012-5. PubMed ID: 19523364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytochromes P450: decision-making tools for personalized therapeutics.
    Murray M; Petrovic N
    Curr Opin Mol Ther; 2006 Dec; 8(6):480-6. PubMed ID: 17243482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic basis of hypertension for the development of tailored medicine.
    Katsuya T; Morishita R; Rakugi H; Ogihrara T
    Hypertens Res; 2009 Aug; 32(8):643-8. PubMed ID: 19543233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antihypertensive pharmacogenetics: getting the right drug into the right patient.
    Turner ST; Schwartz GL; Chapman AB; Hall WD; Boerwinkle E
    J Hypertens; 2001 Jan; 19(1):1-11. PubMed ID: 11204288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bench to bedside: Pharmacogenomics, adverse drug interactions, and the cytochrome P450 system.
    Sikka R; Magauran B; Ulrich A; Shannon M
    Acad Emerg Med; 2005 Dec; 12(12):1227-35. PubMed ID: 16282513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypertension pharmacogenomics: current status and future directions.
    Johnson JA; Turner ST
    Curr Opin Mol Ther; 2005 Jun; 7(3):218-25. PubMed ID: 15977418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic factors in pain and its treatment.
    Stamer UM; Stüber F
    Curr Opin Anaesthesiol; 2007 Oct; 20(5):478-84. PubMed ID: 17873601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are all the hypertensives made equal?
    Flaa A; Kjeldsen SE
    Herz; 2006 Jun; 31(4):323-30. PubMed ID: 16810472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
    Zhou SF; Liu JP; Chowbay B
    Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.